After type 2 diabetes, men showed more heart and kidney diagnoses in a 28,720-person study

A new study followed the sequence, not just the diagnosis

A study published August 25 in PLOS Medicine followed 28,720 people after a new type 2 diabetes diagnosis and found that the next recorded health problems did not unfold in the same proportions for men and women. Using linked UK primary-care, hospital and mortality records from 2010 through 2020, researchers tracked hypertension, cardiovascular disease, end-stage kidney disease and diagnosed anxiety, depression or somatoform disorder over a median 6.8 years. The useful question is not which condition is “a men’s problem.” It is whether follow-up care is looking broadly enough at the heart, kidneys and mental health together.

Men more often entered a heart- or kidney-disease path

Men made up 62% of the cohort and had a median age of 54 when type 2 diabetes was recorded. During follow-up, 39% of the full cohort moved to at least one of the health states the study tracked. Cardiovascular disease or end-stage kidney disease was the next recorded state for 8.4% of men and 5.3% of women. Hypertension was the most common next state for both groups: 21.1% of men and 20.2% of women. These percentages describe diagnoses in this historical UK cohort; they do not tell an individual man what will happen next.

The mental-health result needs careful reading

A diagnosed mental-health condition appeared next for 5.3% of men and 8.1% of women. That does not show that men with diabetes had less distress. The authors said differences in health-care-seeking could influence which conditions were identified, and women in the study used more health services on average. The analysis also could not separate causes of death, examine ethnicity within individual disease paths or establish that sex caused the differences. A lower recorded diagnosis rate can reflect missed care as well as lower underlying risk.

Turn the kidney finding into two specific questions

The American Diabetes Association’s 2026 standards recommend checking a urine albumin-to-creatinine ratio, known as UACR, and estimated glomerular filtration rate, or eGFR, at least annually for every person with type 2 diabetes. One test looks for albumin leaking into urine; the other estimates how well the kidneys filter blood. Ask when each was last checked, what the trend means and when it should be repeated. Do not interpret a single result or change medicine on your own; hydration, illness, medicines and other factors can affect kidney measurements, and abnormal findings often need clinical context or confirmation.

Heart follow-up is more than a glucose number

Current guidance treats blood pressure, cholesterol, smoking, kidney function, medication choices and physical activity as connected parts of cardiovascular risk management. Bring a complete medicine and supplement list to the visit, including anything sold for energy, weight loss or sexual performance. Ask what blood-pressure goal fits your health history, whether cardiovascular or kidney disease changes the preferred diabetes treatment, and which symptoms require urgent care. Chest pressure, signs of stroke, fainting or severe shortness of breath call for 911, not a routine appointment or a wellness session.

Say the hard part out loud

Diabetes care can bring fatigue, cost pressure, fear of complications and the feeling that every meal or reading is a test of character. The CDC distinguishes diabetes distress from depression and anxiety, while noting that they can overlap and interfere with daily care. Tell the care team if you are skipping checks, losing interest in usual activities, sleeping very differently, feeling hopeless or avoiding appointments because the plan feels unmanageable. The ADA recommends depression screening when complications are diagnosed or medical status changes. Call or text 988 for suicidal thoughts or an emotional crisis; call 911 for immediate danger.

What the study should—and should not—change

The result supports coordinated follow-up, not separate self-treatment plans for men and women. It was observational, so it cannot show that earlier testing would have prevented a particular diagnosis or death. It also came from one UK records system and should not be treated as a direct estimate for U.S. communities. Use it as a prompt to ask whether heart risk, kidney tests and mental health have all been reviewed—not as a reason to panic, buy a supplement or alter prescribed treatment. NOCTI provides educational news and helps adults discover independent wellness providers; it does not diagnose or manage diabetes, and massage does not replace medical care.

Sources

• PLOS Medicine: sex differences in health trajectories after type 2 diabetes (August 25, 2026) ↗
• American Diabetes Association: 2026 chronic kidney disease and risk-management standards ↗
• American Diabetes Association: 2026 cardiovascular disease and risk-management standards ↗
• American Diabetes Association: 2026 health-behavior and well-being standards ↗
• CDC: diabetes and mental health ↗
• NIDDK: diabetes, heart disease and stroke ↗